Christopher M. Andreoli, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye Injuries, Penetrating | 12 | 2017 | 115 | 3.210 |
Why?
|
| Vitreoretinopathy, Proliferative | 3 | 2017 | 68 | 0.940 |
Why?
|
| Sclera | 3 | 2014 | 200 | 0.760 |
Why?
|
| Retinal Detachment | 4 | 2017 | 411 | 0.690 |
Why?
|
| Vitreoretinal Surgery | 1 | 2017 | 27 | 0.610 |
Why?
|
| Visual Acuity | 13 | 2017 | 2520 | 0.570 |
Why?
|
| Drug Substitution | 3 | 2015 | 281 | 0.550 |
Why?
|
| Wet Macular Degeneration | 2 | 2015 | 146 | 0.550 |
Why?
|
| Eye Enucleation | 3 | 2012 | 128 | 0.530 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2015 | 2038 | 0.530 |
Why?
|
| Ophthalmologic Surgical Procedures | 3 | 2012 | 349 | 0.460 |
Why?
|
| Macular Edema | 4 | 2016 | 359 | 0.390 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2011 | 215 | 0.350 |
Why?
|
| Eye Foreign Bodies | 1 | 2010 | 55 | 0.350 |
Why?
|
| Diabetic Retinopathy | 6 | 2016 | 1205 | 0.330 |
Why?
|
| Accidents, Occupational | 1 | 2010 | 251 | 0.330 |
Why?
|
| Eye Diseases | 1 | 2014 | 670 | 0.320 |
Why?
|
| Cataract Extraction | 1 | 2011 | 482 | 0.290 |
Why?
|
| Endophthalmitis | 1 | 2009 | 263 | 0.270 |
Why?
|
| Uveomeningoencephalitic Syndrome | 1 | 2006 | 19 | 0.270 |
Why?
|
| Eye Infections, Bacterial | 1 | 2009 | 235 | 0.270 |
Why?
|
| Choroid Neoplasms | 1 | 2006 | 175 | 0.260 |
Why?
|
| Meningitis, Meningococcal | 1 | 2004 | 43 | 0.250 |
Why?
|
| Keratoconjunctivitis | 1 | 2004 | 53 | 0.250 |
Why?
|
| Burkitt Lymphoma | 1 | 2006 | 328 | 0.240 |
Why?
|
| Neisseria meningitidis | 1 | 2004 | 109 | 0.240 |
Why?
|
| Eye | 1 | 2007 | 728 | 0.230 |
Why?
|
| Exudates and Transudates | 3 | 2016 | 171 | 0.230 |
Why?
|
| Conjunctival Neoplasms | 1 | 2004 | 79 | 0.220 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 1369 | 0.220 |
Why?
|
| Sneezing | 1 | 2002 | 17 | 0.210 |
Why?
|
| Trochlear Nerve Diseases | 1 | 2002 | 15 | 0.210 |
Why?
|
| Pupil Disorders | 1 | 2002 | 33 | 0.210 |
Why?
|
| Age Distribution | 4 | 2011 | 2900 | 0.190 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2015 | 664 | 0.190 |
Why?
|
| Diplopia | 1 | 2002 | 199 | 0.190 |
Why?
|
| Blindness | 4 | 2009 | 615 | 0.190 |
Why?
|
| Smoking | 1 | 2017 | 8969 | 0.180 |
Why?
|
| Vitrectomy | 2 | 2016 | 365 | 0.180 |
Why?
|
| Child, Preschool | 10 | 2017 | 40955 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2015 | 3502 | 0.170 |
Why?
|
| Retrospective Studies | 19 | 2017 | 77098 | 0.160 |
Why?
|
| Neurilemmoma | 1 | 2004 | 547 | 0.160 |
Why?
|
| Aged, 80 and over | 12 | 2017 | 57683 | 0.160 |
Why?
|
| Aged | 25 | 2017 | 162944 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2633 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2017 | 23320 | 0.140 |
Why?
|
| Scleral Buckling | 1 | 2016 | 84 | 0.140 |
Why?
|
| Massachusetts | 3 | 2017 | 8662 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2015 | 3770 | 0.130 |
Why?
|
| Adolescent | 13 | 2017 | 85649 | 0.130 |
Why?
|
| Infant | 7 | 2014 | 35070 | 0.130 |
Why?
|
| Middle Aged | 24 | 2017 | 213127 | 0.130 |
Why?
|
| Sex Distribution | 2 | 2011 | 2295 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15244 | 0.130 |
Why?
|
| Retinal Vein Occlusion | 1 | 2015 | 137 | 0.120 |
Why?
|
| Child | 10 | 2017 | 77478 | 0.120 |
Why?
|
| Young Adult | 9 | 2017 | 56350 | 0.120 |
Why?
|
| Male | 27 | 2017 | 349538 | 0.110 |
Why?
|
| Trauma Severity Indices | 2 | 2013 | 481 | 0.110 |
Why?
|
| Ocular Hypertension | 1 | 2014 | 197 | 0.110 |
Why?
|
| Adult | 19 | 2017 | 213712 | 0.100 |
Why?
|
| Retinal Diseases | 2 | 2009 | 683 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 4 | 2016 | 2637 | 0.100 |
Why?
|
| Refraction, Ocular | 1 | 2011 | 181 | 0.090 |
Why?
|
| Time Factors | 4 | 2017 | 40054 | 0.090 |
Why?
|
| Female | 23 | 2017 | 379592 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2016 | 11695 | 0.090 |
Why?
|
| Case-Control Studies | 6 | 2017 | 21719 | 0.090 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 1813 | 0.090 |
Why?
|
| Eye Evisceration | 1 | 2009 | 22 | 0.090 |
Why?
|
| Humans | 34 | 2017 | 742088 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5171 | 0.080 |
Why?
|
| Glaucoma, Neovascular | 1 | 2007 | 33 | 0.080 |
Why?
|
| Recurrence | 2 | 2017 | 8333 | 0.080 |
Why?
|
| Incidence | 3 | 2017 | 20928 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2015 | 6452 | 0.070 |
Why?
|
| Exophthalmos | 1 | 2008 | 96 | 0.070 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 2354 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5062 | 0.070 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2008 | 246 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 8829 | 0.070 |
Why?
|
| Lipids | 1 | 2016 | 3302 | 0.060 |
Why?
|
| Retinal Neovascularization | 1 | 2007 | 244 | 0.060 |
Why?
|
| Body Fluids | 1 | 2006 | 319 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2012 | 1057 | 0.060 |
Why?
|
| Choroidal Neovascularization | 1 | 2007 | 343 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 2271 | 0.060 |
Why?
|
| Ceftriaxone | 1 | 2004 | 168 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 39004 | 0.060 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 370 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2007 | 721 | 0.060 |
Why?
|
| S100 Proteins | 1 | 2004 | 259 | 0.060 |
Why?
|
| Deafness | 1 | 2007 | 461 | 0.060 |
Why?
|
| Needlestick Injuries | 1 | 2003 | 67 | 0.060 |
Why?
|
| Intravitreal Injections | 2 | 2015 | 345 | 0.060 |
Why?
|
| Risk Factors | 6 | 2017 | 72145 | 0.060 |
Why?
|
| Retinopathy of Prematurity | 1 | 2007 | 421 | 0.050 |
Why?
|
| Fluorescein Angiography | 1 | 2006 | 936 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 13019 | 0.050 |
Why?
|
| Limbus Corneae | 1 | 2004 | 142 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2014 | 5978 | 0.050 |
Why?
|
| Penicillins | 1 | 2004 | 378 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1849 | 0.050 |
Why?
|
| Retinal Artery Occlusion | 1 | 2002 | 74 | 0.050 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2002 | 73 | 0.050 |
Why?
|
| Meckel Diverticulum | 1 | 2001 | 34 | 0.050 |
Why?
|
| Cataract | 1 | 2007 | 833 | 0.050 |
Why?
|
| Phacoemulsification | 1 | 2003 | 149 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 233 | 0.050 |
Why?
|
| HIV Seropositivity | 1 | 2006 | 970 | 0.050 |
Why?
|
| Optic Neuritis | 1 | 2002 | 166 | 0.050 |
Why?
|
| Injections | 1 | 2003 | 840 | 0.050 |
Why?
|
| Macular Degeneration | 1 | 2007 | 980 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 6483 | 0.040 |
Why?
|
| Optic Nerve Diseases | 1 | 2003 | 327 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2009 | 7153 | 0.040 |
Why?
|
| Strabismus | 1 | 2002 | 287 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2009 | 8621 | 0.040 |
Why?
|
| Retina | 1 | 2009 | 2611 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15056 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 19862 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2003 | 984 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2016 | 211 | 0.030 |
Why?
|
| Macula Lutea | 1 | 2016 | 151 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2016 | 62966 | 0.030 |
Why?
|
| Hyphema | 1 | 2014 | 26 | 0.030 |
Why?
|
| Luteal Phase | 1 | 1994 | 147 | 0.030 |
Why?
|
| Follicular Phase | 1 | 1994 | 153 | 0.030 |
Why?
|
| Pain | 1 | 2009 | 4961 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2004 | 12958 | 0.030 |
Why?
|
| Lens, Crystalline | 1 | 2014 | 388 | 0.030 |
Why?
|
| Vision Tests | 1 | 2011 | 167 | 0.020 |
Why?
|
| Observer Variation | 1 | 2016 | 2593 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2016 | 8541 | 0.020 |
Why?
|
| Prognosis | 5 | 2014 | 29010 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2015 | 2615 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2014 | 1274 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2007 | 25575 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 1989 | 268 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 4742 | 0.020 |
Why?
|
| Orbital Neoplasms | 1 | 2008 | 225 | 0.020 |
Why?
|
| Photography | 1 | 2008 | 521 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2007 | 23387 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6534 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2015 | 9846 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6249 | 0.010 |
Why?
|
| Temporal Arteries | 1 | 2002 | 128 | 0.010 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2003 | 193 | 0.010 |
Why?
|
| Anesthesia, Local | 1 | 2003 | 268 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 12946 | 0.010 |
Why?
|
| Arteritis | 1 | 2002 | 159 | 0.010 |
Why?
|
| Optic Nerve | 1 | 2002 | 548 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2003 | 35342 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2924 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2013 | 9144 | 0.010 |
Why?
|
| Intestinal Obstruction | 1 | 2001 | 424 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 3336 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18355 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12220 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 1994 | 20774 | 0.010 |
Why?
|
| Health Personnel | 1 | 2008 | 3210 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17400 | 0.010 |
Why?
|
| Axilla | 1 | 1994 | 588 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 7141 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 53187 | 0.010 |
Why?
|
| Biopsy | 1 | 2002 | 6756 | 0.010 |
Why?
|
| Premenopause | 1 | 1994 | 1033 | 0.010 |
Why?
|
| United States | 1 | 2016 | 69693 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 12017 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1994 | 3465 | 0.000 |
Why?
|
| Survival Rate | 1 | 1994 | 12773 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1994 | 12344 | 0.000 |
Why?
|
| Radiography | 1 | 1989 | 7010 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 20086 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1994 | 9185 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1989 | 12242 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1994 | 13655 | 0.000 |
Why?
|